Appeals Court Holds US Humira Patents Invalid
Upholds 2017 Inter Partes Review Decisions On Three Patents
The US Court of Appeals for the Federal Circuit has upheld a series of inter partes review decisions from 2017 in which three Humira patents were found invalid by the Patent Trial and Appeal Board within the US Patent and Trademark Office.
